cdr3.alpha	v.alpha	j.alpha	cdr3.beta	v.beta	d.beta	j.beta	species	mhc.a	mhc.b	mhc.class	antigen.epitope	antigen.gene	antigen.species	reference.id	submitter	method.identification	method.frequency	method.singlecell	method.sequencing	method.verification	meta.study.id	meta.cell.subset	meta.subset.frequency	meta.subject.cohort	meta.subject.id	meta.replica.id	meta.clone.id	meta.epitope.id	meta.tissue	meta.donor.MHC	meta.donor.MHC.method	meta.structure.id	comment
			CASSPQTGTGGYGYTFG	TRBV6-5		TRBJ1-2	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.085	healthy	1				PBMC	HLA-A2	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV13.1
			CASSPQTGTGGYGYTFG	TRBV6-5		TRBJ1-2	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.07	healthy	2				PBMC	HLA-A2	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV13.1
			CASSPLFGTSGGETYYFG	TRBV6-5		TRBJ2-5	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.07	healthy	2				PBMC	HLA-A2	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV13.1
			CASSPQTGTGGYGYTFG	TRBV6-5		TRBJ1-2	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.024	healthy	4				PBMC	HLA-A2	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV13.1
			CASSPQTGASYGYTFG	TRBV6-5		TRBJ1-2	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.024	healthy	4				PBMC	HLA-A2	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV13.1
			CASSLVGGRYGYTFG	TRBV12-3		TRBJ1-2	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.024	healthy	4				PBMC	HLA-A2	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV8
			CASSPQTGTGGYGYTFG	TRBV6-5		TRBJ1-2	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.017	healthy	5				PBMC	HLA-A2	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV13.1
			CASSPATGTIYGYTFG	TRBV6-5		TRBJ1-2	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.017	healthy	5				PBMC	HLA-A2	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV13.1
			CASSLTSGSPDTQYFG	TRBV27		TRBJ2-3	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.017	healthy	5				PBMC	HLA-A2	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV14
CATVLRMDSSYKLIFG	TRAV3	TRAJ16-5	CASSILGVSSYNEQFFG	TRBV7-6		TRBJ2-1	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.23	healthy	25				PBMC	HLA-A2;HLA-B7	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV6.4
			CASSFRDYGRYEQYFG	TRBV7-6		TRBJ2-7	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.038	healthy	27				PBMC	HLA-A2;HLA-B7	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV6.4
			CASSILGISSYNEQFFG	TRBV7-6		TRBJ2-1	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.036	healthy	29				PBMC	HLA-A2,HLA-A2;HLA-B7	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV6.4
			CASSLGPITEAPFG	TRBV27		TRBJ1-1	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.059	healthy	30				PBMC	HLA-A2;HLA-B7	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV14
CAVRVSMDSSYKLIFG	TRAV16	TRAJ16-5	CASSPSAQYNEQFFG	TRBV7-6		TRBJ2-1	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.065	healthy	40				PBMC	HLA-B7	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV6.4
			CASSLRGAATDTQYFG	TRBV7-6		TRBJ2-1	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.065	healthy	40				PBMC	HLA-B7	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV6.4
CAMREGRDSSYKLIFG	TRAV6	TRAJ16-5	CASTNHDRGGMNTEAPFG	TRBV7-6		TRBJ1-1	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.073	healthy	41				PBMC	HLA-B7	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV6.4
CAVRVSMDSSYKLIFG	TRAV16	TRAJ16-5	CASTNHDRGGMNTEAPFG	TRBV7-6		TRBJ1-1	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.073	healthy	41				PBMC	HLA-B7	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV6.4
			CASSLVGQGLSDEQFFG	TRBV7-6		TRBJ2-1	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-sort			sanger			CD8	0.035	healthy	43				PBMC	HLA-B7	Ab,PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV6.4